Carbonic anhydrase inhibitors. Part 54 - Metal complexes of heterocyclic sulfonamides: A new class of antiglaucoma agents

Metal-Based Drugs

Volumn 4, Issue 6, 1997, Pages 307-315

  Supuran, Claudiu T ^a   Scozzafava, Andrea ^a   Jitianu, Andrei ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b INSTITUTE OF PHYSICAL CHEMISTRY   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM DERIVATIVE; ANTIGLAUCOMA AGENT; BERYLLIUM; CADMIUM DERIVATIVE; CARBONATE DEHYDRATASE; CARBONATE DEHYDRATASE INHIBITOR; MAGNESIUM DERIVATIVE; MERCURY DERIVATIVE; SULFONAMIDE; ZINC DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG SYNTHESIS; INTRAOCULAR DRUG ADMINISTRATION; INTRAOCULAR PRESSURE; MALE; NONHUMAN; PARENT; PHYSICAL CHEMISTRY;

EID: 0031470601     PISSN: 07930291     EISSN: None     Source Type: Journal    
DOI: 10.1155/MBD.1997.307     Document Type: Article

References (46)

1. Preceding part of this series: Supuran CT, Scozzafava A, Hies MA, Iorga B, Cristea T, Chiraleu F, Banciu MD (1997) Eur J Med Chem, submitted.
2. Supuran CT (1994) "Carbonic anhydrase inhibitors" In Carbonic Anhydrase and Modulation of Physiologic and Pathologic Processes in the Organism, (Puscas I, Ed) Helicon, Timisoara, pp. 29-111.
3. Maren TH (1991) "The links among biochemistry, physiology and pharmacology in carbonic anhydrase mediated systems". In Carbonic Anhydrase - From Biochemistry and Genetics to Physiology and Clinical Medicine, (Botre F, Gros G, Storey BT Eds) VCH, Weinheim, pp. 186-207.
4. Bayer A, Ferrari F, Maren TH, Erb C (1996) J Fr Ophtalmol 19, 357-362.
5. Maren TH, Conroy CW, Wynns GC, Levy NS (1997) J Ocul Pharmacol Therapeut 13, 23-30.
6. Sugrue MF (1996) J Ocul Pharmacol Ther 12, 363-376.
7. Bartlett JD, Jaanus SD (1989) "Carbonic anhydrase inhibitors". In Clinical Ocular Pharmacology, Second Edition, Butterworths Publishers, Boston, pp. 254-263.
8. Alward PD, Wilensky JT (1981) Arch Ophthalmol 99, 1973-1976.
9. Maren TH, Jankowska L, Sanyal G, Edelhauser HF (1983) Exp Eye Res 36, 457-480.
10. a) Ponticello GS, Freedman MB, Habecker CN, Lyle PA, Schwam H, Varga SL, Christy ME, Randall WC, Baldwin JJ (1987) J Med Chem 30, 591-597;
11. b) Greer J, Erickson JW, Baldwin JJ, Varney MD (1994) J Med Chem 37, 1035-1054.
12. Baldwin JJ, Ponticello GS, Anderson GS, Christy ME, Murcko MA, Randall WC, Schwam H, Sugrue MF, Springer JP, Gautheron P, Grove J, Mallorga P, Viader MP, McKeever BM, Navia MA (1989) J Med Chem 32, 2510-2513.
13. Chow K, Lai R, Holmes JM, Wijono M, Wheeler LA, Garst ME (1996) Eur J Med Chem 31, 175-186.
14. Supuran CT, Nicolae A, Popescu A (1996) Eur J Med Chem 31, 431-438.
15. Supuran CT, Popescu A, Ilisiu M, Costandache A, Banciu MD (1996) Eur J Med Chem 31, 439-448.
16. Supuran CT, Scozzafava A, Popescu A, Bobes-Tureac R, Banciu A, Creanga A, Bobes-Tureac G, Banciu MD (1997) Eur J Med Chem 32, 445-452.
17. Alzuet G, Casanova J, Ramirez J A, Borras J, Carugo O (1995) J Inorg Biochem 57, 219-234.
18. Sumalan SL, Casanova J, Alzuet G, Borras J, Castiñeiras A, Supuran CT (1996) J Inorg Biochem 62, 31-39.
19. a) Supuran CT (1995) Metal Based Drugs 2, 327-330;
20. b) Scozzafava A, Supuran CT (1997) Metal Based Drugs 4, 19-26.
21. a) Borras J, Cristea T, Supuran CT (1996), Main Group Met Chem 19, 339-346;
22. b) Jitianu A, Hies MA, Brigand F, Scozzafava A, Supuran CT (1997) Metal Based Drugs 4, 1-7.
23. a) Supuran CT, Scozzafava A (1997) J Enzyme Inhibition 12, 37-51;
24. b) Supuran CT, Briganti F, Scozzafava A (1997) J Enzyme Inhibition 12, 175-190.
25. Mincione G, Scozzafava A, Supuran CT (1997) Metal Based Drugs 4, 27-34.
26. Alzuet G, Ferrer S, Borras J, Supuran CT (1994) Roum Chem Quart Rev 2, 283-300.
27. Briganti F, Mangani S, Orioli P, Scozzafava A, Vernaglione G, Supuran CT (1997) Biochemistry 36, 10384-10392.
28. Borras J, Casanova J, Cristea T, Gheorghe A, Scozzafava A, Supuran CT, Tudor V (1996) Metal Based Drugs 3, 143-148.
29. Supuran CT, Mincione F, Scozzafava A, Briganti F, Mincione G, Hies MA (1997) Eur J Med Chem, in press.
30. Supuran CT, Scozzafava A, Saramet I, Banciu MD (1997) J Enzyme Inhibition, in press.
31. Jitianu A, Hies MA, Scozzafava A, Supuran CT (1997) Main Group Met Chem 20, 151-156.
32. Forsman C, Behravan G, Osterman A, Jonsson BH (1988) Acta Chem Scand B 42, 314-318.
33. Behravan G, Jonasson P, Jonsson BH, Lindskog S (1991) Eur J Biochem 198, 589-592.
34. Khalifah RG, Strader DJ, Bryant SH, Gibson SM (1977) Biochemistry 16, 2241-2247.
35. Nyman PO, Lindskog S (1964) Biochim Biophys Acta 85, 141-151.
36. Henderson LE, Henriksson D, Nyman PO (1976) J Biol Chem 251, 5457-5463.
37. Maren TH, Wynns GC, Wistrand PJ (1993) Mol Pharmacol 44, 901-906.
38. Young RW, Wood KH, Vaughan JR, Anderson GW (1956) J Am Chem Soc 78, 4649-4654.
39. Pocker Y, Stone JT (1967) Biochemistry 6, 668-678.
40. Baird TT, Waheed A, Okuyama T, Sly WS, Fierke CA (1997) Biochemistry 36, 2669-2678.
41. Maren TH, Bar-Ilan A, Conroy CW, Brechue WF (1990) Exp Eye Res 50, 27-36.
42. Maren TH, Brechue WF, Bar-Ilan A (1992) Exp Eye Res 55, 73-79.
43. Brechue WF, Maren TH (1993) Invest Ophthalmol Vis Sci 34, 2581-2587.
44. Borja P, Alzuet G, Server-Carrio J, Borras J, Supuran CT (1997) J Biol Inorg Chem (JBIC), in press.
45. Supuran CT, Balaban AT, Gheorghiu MD, Schiketanz A, Dinculescu A, Puscas I (1990) Rev Roum Chim 35, 399-405.
46. Supuran CT, Scozzafava A (1997) unpublished results.